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ABSTRACT
Background: Hyperbaric oxygenation (HBO) therapy aims to increase oxygen tissue pres ­
sure by at least 10 times and decrease the adverse effects of ischemia. The aim of this study 
was to investigate the effect of HBO on the immunohistochemical expressions of caspase 
3 and vascular endothelial growth factor (VEGF) in random flaps in rats. Methods: Thir­
ty­two male Wistar rats were randomly divided into 4 groups: the sham group (GS), the 
N­acetylcysteine group (GNAC), the HBO group, and the HBO + N­acetylcysteine group. 
A rectangular skin flap (2 × 8 cm) was dissected from the dorsal muscle layer, and a cranial 
pedicle was preserved. A polyethylene film was placed on the muscle layer, and the flap 
was fixed in the original site. On the eighth day, biopsy samples (2 × 1 cm) of the entire 
thickness of the proximal, medial, and cranial areas as well as of the site outside the flap, 
which was used as a control, were collected. Results: VEGF expression in the skin layers 
and vessels was not significantly different between the groups. The number of apoptotic 
cells was significantly increased in the area of the flap in all groups. The highest increase 
was noted in the GS and GNAC groups. HBO significantly reduced the number of caspase 
3­positive cells in the skin layers and vessels of the 3 areas. Conclusions: HBO was asso­
ciated with decreased apoptosis. VEGF expression in the skin layers and vessels did not 
differ significantly. The results suggest that oxygen diffusion through the interstitial space 
was the determining factor for the positive effect of HBO on the decrease in apoptosis.
Keywords: Hyperbaric oxygenation. Caspase 3. Endothelial growth factors. Surgical flaps.
RESUMO
Introdução: A oxigenação hiperbárica (OHB) tem por objetivo aumentar em pelo menos 
10 vezes a pressão tecidual de oxigênio, diminuindo os efeitos deletérios da isquemia. O 
objetivo deste estudo é investigar o papel da oxigenação hiperbárica na expressão imu­
no­histoquímica da caspase 3 e do fator de crescimento endotelial vascular (VEGF) em 
retalhos randômicos em ratos. Método: Trinta e dois ratos Wistar machos foram divididos 
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aleatoriamente em quatro grupos: grupo sham (GS), grupo N­acetilcisteína (GNAC), gru­
po OHB (GOHB) e grupo OHB + N­acetilcisteína (GHN). Um retalho de pele retangular 
(2 cm x 8 cm) foi dissecado a partir da camada muscular dorsal, preservando um pedículo 
cranial. Uma lâmina de polietileno foi colocada sobre a camada muscular e fixou­se o 
retalho no local original. No 8o dia, foram coletadas biópsias (2 cm x 1 cm) de espessura 
total das áreas proximal, média e cranial e de um local fora do retalho, que serviu como 
área de controle. Resultados: A expressão de VEGF nas camadas da pele e nos vasos não 
apresentou diferenças significativas entre os grupos. As células apoptóticas estavam signi­
ficativamente aumentadas na área central do retalho em todos os grupos. O maior aumento 
ocorreu nos grupos GS e GNAC. A OHB diminuiu significativamente o número de células 
caspase 3 positivas nas camadas da pele e nos vasos das três áreas. Conclusões: A OHB 
foi associada a expressão reduzida de apoptose. A expressão de VEGF em camadas da 
pele e vasos não demonstrou diferença significativa. Os resultados sugerem que a difusão 
do oxigênio através do espaço intersticial foi o fator determinante para os resultados mais 
favoráveis da OHB na diminuição da expressão de apoptose. 
Descritores: Oxigenação hiperbárica. Caspase 3. Fatores de crescimento endotelial. Reta­
lhos cirúrgicos.
INTRODUCTION
Hyperbaric oxygenation (HBO) is a form of therapy in 
which 100% medicinal oxygen is supplied under pressure to 
increase the oxygen pressure in tissues by at least 10 times and 
reduce the adverse effects of ischemia. This type of treatment 
has been used since 1968, when its clinical indications were 
defined. In plastic surgery, HBO is indicated for the treat­
ment of patients with severe burns and for ischemic flaps 
because it provides hyperoxygenation to tissues, activates 
fibroblasts, modulates inflammatory response, accelerates 
growth factors, and has antibacterial activity1­5.
McFarlane et al.6 developed an experimental model to 
assess the viability of random flaps in rats, which had been 
used in various previous studies. The authors observed that 
the biochemical and morphological changes were directly 
related to the distance from the extremity of the flap and the 
size of its pedicle7­9.
Random flaps are exposed to tissue damage resulting from 
postischemic reperfusion, in which reintroduction of mo le­
cular oxygen facilitates the production of critical levels of 
energy, increasing the inflammatory response and cau sing 
to xicity in endothelial cells. N­Acetylcysteine (NAC) is a 
prodrug that regulates the glutathione levels in the bo dy when 
they are reduced in the presence of toxic oxygen radicals 
(TORs). Glutathione is one of the most potent free radical 
sca vengers, and its cellular levels are quickly de pleted during 
damage caused by the ischemia­reperfusion phenomenon6,10­12.
The aim of this study was to assess the effect of HBO, 
NAC, and their association on random flaps in rats by using 
an apoptosis marker (cleaved caspase 3) and an endothelial 
vascular growth marker (VEGF).
METHODS
Ethical Considerations
The experimental protocol (0321/06) was approved by 
the ethics committee of the Federal University of São Paulo. 
All procedures were conducted in strict accordance with 
the existing regulations on animal experimentation of the 
Colégio Brasileiro de Experimentação Animal.
Samples and Groups
Thirty­two male Wistar rats weighing 280 to 300 g were 
kept in individual cages in a sound­attenuated room main­
tained at 25oC under artificial lighting and given food and 
water ad libitum. The animals were randomly divided into 4 
groups as follows:
• GS – the sham group, including 8 animals;
• GNAC – the NAC group, including 8 animals;
• GHBO – the HBO group, including 8 animals;
• GHN – the HBO + NAC group, including 8 animals.
Anesthesia Procedure
After 6 h of solid food fasting and 4 h of liquid fasting, the 
animals received 5 mg/kg of 0.2% acepromazine, intramus­
cular. Ten minutes later, the animals received a combination 
of 50 mg/kg­1 of ketamine hydrochloride and 10 mg/kg­1 
xylazine hydrochloride, intramuscular.
Surgical Procedure
Under general anesthesia, trichotomy of dorsal regions 
was performed, and the animals were then fixed in the prone 
position. After demarcation of a rectangular patch (2 cm 
× 8 cm) of upper base, incision with a scalpel (blade No. 
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15) was performed, then the flap was dissected, including 
epidermis and dermis (Figure 1). A polyethylene film was 
interposed between the flap and the muscle layer, covering 
the entire area of the wound and acting as a barrier between 
the skin and muscles (Figure 2). Then, flap synthesis with 
polyamide thread 3.0 was performed, fixing the flap in its 
original position.
Administration Procedures
Animals in the GNAC and GHN groups were intraperito­
neally injected with 300 mg/kg of NAC (Fluimucil®; Zambon 
Laboratório Farmacêutico Ltda., São Paulo, SP, Brazil) after 
flap elevation and then every 24 hours for 7 days.
The animals in the GS and GHBO groups were intrape­
ritoneally injected with 1 ml of distilled water (Isofarma, 
São Paulo, SP, Brazil) after flap elevation and then every 24 
hours for 7 days.
HBO Procedures
A hyperbaric chamber for several animals was used. 
Be fore pressurization, the inside of the chamber was cleaned 
with 100% medicinal oxygen for 5 minutes. The chamber 
was then pressurized until a pressure of 2.4 atmosphere 
absolute (ATA). The oxygen concentration was monitored 
using a calibrated oximeter. All animals in the GHBO and 
GHN groups were exposed to 100% of oxygen at a pressure 
of 2.4 ATA for 2 hours (once/day), starting 15 minutes after 
the surgery and then every 24 hours for 7 consecutive days.
Treatment
The animals were randomly divided into the following 
groups:
• the GS group (n = 8), received distilled water intra­
peritoneally 15 minutes after flap elevation and then 
for 7 consecutive days;
• the GNAC group (n = 8), received 300 mg/kg­1 NAC 
intraperitoneally after flap elevation and then for 7 
consecutive days;
Figure 1 – Standard random skin flap (2 × 8 cm)  
by McFarlane et al.6 on the seventh cervical vertebra.
Figure 2 – Polyethylene film placed on the muscle layer,  
covering the entire area of the wound and acting as a  
barrier between the skin and the muscle.
Figure 3 – Areas from where biopsy samples were collected.
• the GHBO group (n = 8), received 100% oxygen at 
2.4 ATA in a hyperbaric environment for 7 consecu­
tive days for 2 hours;
• the GHN group (n = 8), received a combination of 
oxygen in a hyperbaric environment and NAC in ­
traperitoneally for 7 consecutive days.
Sample Collection
On the eighth day of the experiment, the rats were 
once again anesthetized for collection of incisional biopsy 
samples (2 × 1 cm), which included the entire thickness of the 
proximal, medial, and distal areas of the flap. As a control, 
another biopsy sample was collected from outside the area 
of the flap (Figure 3).
Euthanasia
Under anesthesia, the animals were euthanized in a carbon 
dioxide chamber after sample collection.
Histological Procedure
The samples were fixed in 10% formalin, embedded in 
paraffin, and immunohistochemically stained to examine the 
expression of the apoptosis marker and VEGF.
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Immunohistochemical Staining for VEGF
An anti­VEGF marker (Sigma Chemical Company, St. 
Louis, USA) was used to detect VEGF expression. All 
pro cedures were performed according to the manufacturer 
instructions.
Immunohistochemical Staining for the  
Apoptosis Marker
The avidin­biotin standard method was used to detect 
apoptotic cells using a detection kit containing anti­caspase 
3 primary antibody (Lexington, USA). After incubation, the 
specimens were treated with rabbit immunoglobulin/bio ­
tinylated antibody (at 1:600 dilution; Dako Ltd., Ely, UK) 
for 30 min. All procedures were performed according to the 
manufacturer instructions.
VEGF Expression
Medium­power magnification (´100 and ´200) was used 
to examine VEGF expression in the biopsy samples from 
the epidermis, dermis, vessels, and submuscular area. VEGF 
expression was classified according to the intensity of the 
color of the cytoplasm (from 0 to 3):
• 0 – no expression (negative reaction);
• 1 – low expression (weak brown reaction);
• 2 – moderate expression (moderate brown reaction);
• 3 – high expression (strong brown reaction).
Apoptosis Marker Expression
Images were obtained using a high­resolution camera with 
Axiomcam software (Mission­oriented Resilient Clouds; 
Zeiss®) and analyzed using an optical microscope (Carl Zeiss 
Axiolab®). Axiovision Rel 4.2 software (Zeiss®) was used 
to calculate the ratio of brown cells (i.e., apoptotic cells) to 
non­bro wn cells (i.e., non­apoptotic cells). Apoptotic cells 
were counted in 10 fields per slide in all the samples for all 
the groups.
Statistical Analysis
All procedures for histological and immunohistochemical 
analyses were performed with the examiner blinded to the iden­
tity of the groups to which the morphological samples belonged.
For the analysis of the immunohistochemical results, 
non parametric tests were applied, taking into consideration 
the variables under study and the sample size. Two variables 
were analyzed, a quantitative variable (cleaved caspase 3) 
and a semiquantitative variable (VEGF).
Cleaved caspase 3 levels were expressed as mean and 
standard deviation values. VEGF expression was presented 
as a score, and mean and standard deviation values were 
obtained for each group. Analysis of variance was performed 
to determine within­group differences, and the Bonferroni 
test was used to compare the groups.
The probability of rejecting the null hypothesis was set at 
0.05 or 5%, and a P value of <0.05 was considered statistically 
significant (with a 95% confidence interval).
RESULTS
Regarding VEGF expression, all the biopsy samples 
col lected from the distal third exhibited necrosis. Data on 
Table 1 – Mean, standard deviation, and P value for VEGF expression in 10 fields per slide in all the samples collected  
for each third from all the groups.
Tissue Third
GS GNAC GHBO GHN
P value*
Mean ± SD Mean ± SD Mean ± SD Mean ± SD
Epidermis
Control 2 ± 0.6 2.8 ± 0.3 2.2 ± 0.9 2.4 ± 0.5 0.1
Medial 1.8 ± 0.8 2.6 ± 0.7 2.3 ± 1 1.7 ± 1 0.2
Proximal 2.3 ± 0.7 2.7 ± 0.7 2.6 ± 0.5 2.7 ± 0.5 0.5
Dermis
Control 1.5 ± 0.5 2 ± 0.7 2 ± 0.5 1.4 ± 0.5 0.06
Medial 1.9 ± 0.8 1.7 ± 0.7 1.6 ± 0.7 1.5 ± 0.5 0.7
Proximal 1.6 ± 0.5 1.9 ± 0.8 1.4 ± 0.7 1.5 ± 0.5 0.5
Submuscular
Control 1.2 ± 0.7 2 ± 0.5 2 ± 1.2 1 ± 0.5 0.06
Medial 2.3 ± 0.8 2.1 ± 0.4 1.9 ± 0.6 2.2 ± 0.9 0.7
Proximal 1.6 ± 0.7 1.3 ± 1 1.3 ± 0.7 2 ± 0.8 0.2
Vessels
Control 1.6 ± 0.8 2 ± 0.1 2.4 ± 0.7 2.1 ± 0.8 0.1
Medial 2.3 ± 0.7 2.1 ± 0.6 2.3 ± 0.5 2.3 ± 0.5 0.8
Proximal 1.8 ± 0.6 2.1 ± 0.6 2 ± 0.7 2.1 ± 0.6 0.8
 *Analysis of variance.
SD = standard deviation; GHN = GNAC + GHBO group; GNAC = N­acetylcysteine group; GHBO = hyperbaric oxygenation group; GS = sham group.
Rev Bras Cir Plást. 2013;28(2):183-90 187
Does hyperbaric oxygenation have a protective effect on random skin flaps?
VEGF expression in the epidermis, dermis, panniculus car ­
nosus, and vessels showed that HBO did not promote any 
significant change in both the GS and the GNAC groups 
(Table 1). Moreover, no significant difference was observed 
in the GHN group. These findings suggest that OHB, NAC, 
or the combination of both did not promote changes in VEGF 
expression in the tissues.
HBO caused a significant reduction in apoptotic cells in 
all the biopsy samples obtained from the proximal and medial 
thirds. The combination of HBO and NAC, in addition to not 
having a protective effect, exerted a negative effect (Figu res 
4 and 5).
Statistical analysis of the biopsy data for the proximal, 
medial, and distal thirds of the flaps showed that sham (GS) 
group had greatest number of apoptotic cells followed by 
the NAC and GHN groups. The GHBO group presented 
fewer cells apoptosis in all strata of the epithelium under 
study (epidermis, dermis, submuscular area, and vessels), 
as shown in Table 2.
DISCUSSION
The mean oxygen tension in ischemic flaps is only 30 
mmHg. Hypoxia occurs as a normal stimulus for wound 
healing; however, this situation can deteriorate if the local 
conditions of poor irrigation persist, thus impairing wound 
healing and leading to tissue necrosis13.
During the ischemic period, random flaps are subjected 
to hypoxia and hypoglycemia. These conditions lead to 
cel lular dysfunction and cell death. When blood flow is res ­
tored, a second event known as flow/no­reflow occurs; this 
phenomenon is the result of the accumulation (plug) of poly­
morphonuclear cells that adhere to the endothelium and are 
responsible for the production of TORs, which are associated 
with the second wave of cellular damage1,14.
TORs are responsible for oxidative damage that leads to 
mitochondrial changes; adenosine triphosphate depletion; 
in crease in intracellular calcium levels; and protease, phos­
phatase, lipase, and nuclease activation, which results in the 
loss of cellular integrity14.
The phenomenon of ischemia/reperfusion is mediated by 
TORs. These molecules are highly unstable and extremely 
toxic to most biological processes by means of their effects 
of lipid peroxidation of cell membranes, formation of free 
radicals in a self­propagating cycle, and cell death due to 
necrosis or apoptosis5.
Studies support the hypothesis that oxygen functions as a 
signaling molecule for a series of events that promote wound 
healing. The levels of hypoxia­inducible factor alpha (HIF­α) 
are decreased in HBO­treated tissues. HIF­α is an important 
regulator of genetic expression involved in the regulation of 
tissue oxygenation, and its levels increase in the presence 
of hypoxia. The level of the protein BNip3 (a pro­apoptotic 
protein located in the mitochondria) increases greatly after 
the 10th day in ischemic tissues. High levels of oxygen 
induced by HBO decrease and attenuate the expression of 
the protein BNip3, thus modulating apoptosis despite the 
persistent high level of lactic acid1,4,5,15.
Therefore, HBO increases antiapoptotic activity and de ­
creases pro­apoptotic activity; there is a subsequent reduction 
in the release of pro­apoptotic molecules by mitochondria 
and attenuation of apoptosis. The molecular basis of the 
protective effect of HBO on ischemic wound healing is at ­
tri butable to HIF­1α modulation. Wounds treated with HBO 
exhibit reduced levels of HIF­1α and a consequent reduction 
in expression of the HIF­1α gene, as well as reduced apoptosis 
and inflammation1,4,5.
The process of angiogenesis begins between the first and 
third days after ischemia and is modulated by growth factors 
that are present in endothelial cells and in the extracellular 
matrix. VEGF is the most important stimulator of angioge­
nesis and its expression is associated with the initiation of 
vascular neoformation. In addition, it is a reliable marker for 
monitoring the process of vascular neoformation15­18.
Caspase 3 is an apoptosis­effector protein. It converts 
cytoplasmic DNAse into an active form. During cell death 
programming, caspase 3 induces early activation of endonu­
Figure 4 – Photomicrographs of the GS, GNAC, GHBO,  
and GHN groups, showing caspase 3 expression (brown color) in 
the hypodermis samples collected from the medial part of the flap 
(original magnification ´200). GHN = GNAC + GHBO group; 
GNAC = N-acetylcysteine group; GHBO = hyperbaric  
oxygenation group; GS = sham group.
Figure 5 – Photomicrographs of the GS, GNAC, GHBO,  
and GHN groups, showing caspase 3 expression (brown color) 
in the vessels collected from the medial part of the flap (original 
magnification ´400). GHN = GNAC + GHBO group;  
GNAC = N-acetylcysteine group; GHBO = hyperbaric  
oxygenation group; GS = sham group.
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cleases, causes DNA fragmentation, and impairs enzymatic 
processes that are vital to cells. Caspase 3 has been used in 
previous studies on ischemic skin flaps5,19.
Many mechanisms are involved in tissue healing; ho ­
wever, most studies show that the presence of growth factors 
is associated with the production of energy derived from 
glycolysis and the Krebs cycle.
HBO increases oxygen tissue pressure by up to 10 times 
by supplying oxygen dissolved in plasma, according to the 
laws of Henry and Boyle; in addition, it acts directly on neu ­
trophils and inflammatory mediators responsible for tissue 
damage.
Humans have a complex antioxidant system. Glutathione 
is depleted during antioxidation. NAC is a prodrug that re ­
plenishes the levels of glutathione when these are depleted 
during the oxidative process and has been used in many 
experimental studies because of its low toxicity and protec­
tive effect on random flaps.
Data regarding VEGF expression in the epidermis, der ­
mis, panniculus carnosus, and vessels indicate that HBO did 
not promote any significant change (Table 2). The propo sed 
mechanism to explain the absence of increased VEGF produc­
tion is that the partial pressure of oxygen does not return to 
the pre­ischemic levels between hyperoxygenation sessions; 
therefore, there is no stimulus for VEGF production5.
Because VEGF expression is upregulated under ischemic 
conditions, we did not expect VEGF expression to be upre­
gulated in the groups treated with HBO (GHBO and GHN), 
in which higher amounts of oxygen were supplied. However, 
a significant increase should have been observed in the GS 
group. The most plausible hypothesis to explain the results 
of this study is the significant reduction in metabolic activity 
and protein synthesis caused by ischemia, which inhibits 
VEGF expression20.
Another hypothesis that may explain the results of this 
study was previously put forward by other authors, who ob ­
served significant decreases in metabolic activity and protein 
synthesis, including the synthesis of VEGF, under ischemic 
conditions20.
The high concentrations of NAC used in the GNAC group 
might have been responsible for the inhibition of VEGF 
production. Previous studies have shown that high concen­
trations of NAC inhibit angiogenesis and the wound healing 
response through an oxidant/antioxidant balance that has not 
yet been clarified11. However, in this study, VEGF expression 
was not altered in any of the groups, and all groups had a 
profile similar to the GS group.
The model used in this study, in which a polyethylene 
film was applied, might have been responsible for the ab ­
sence of VEGF expression in the groups treated with NAC 
 Table 2 – Mean, standard deviation, and P value for the presence of apoptotic cells (caspase 3)  
in 10 fields per slide in all the samples collected for each third from all the groups.
Tissue Third
GS GNAC GHBO GHN
P value***
Mean + SD Mean + SD Mean + SD Mean + SD
Epidermis
Control 2.1 (0.6) 2.4 (0.7) 1.4* (0.5) 2 (0.8) < 0.03
Medial 4.1 (1.3) 3.8 (1.2) 1.9** (0.4) 2.8€ (0.7) < 0.01
Proximal 3.1 (1.3) 2.9 (0.4) 1.1§ (0.6) 1.5¥ (0.5) < 0.01
Dermis
Control 0.8 (0.9) 1.3 (0.5) 0.4 (0.5) 0.8 (0.7) 0.09
Medial 2.1 (1.1) 1.8 (0.5) 0.5* (0.8) 1.3 (0.9) < 0.01
Proximal 1.1 (0.6) 1.5 (0.8) 0.1§ (0.4) 1.1 (1) < 0.01
Submuscular
Control 1.5 (1.2) 1.8 (0.7) 1.1 (0.4) 1.8 (0.7) 0.06
Medial 3.8 (2) 2.3 (0.9) 1.6* (0.5) 2.4 (1.2) < 0.01
Proximal 3 (1.2) 2 (1.1) 1.1** (0.4) 1.8¥ (0.5) < 0.01
Vessels
Control 1.3 (1.3) 1.8 (0.5) 1.1 (0.4) 1.9 (0.6) 0.1
Medial 3.6 (1.8) 2.4 (0.9) 1.5* (0.5) 2.6 (0.5) < 0.01
Proximal 2.9 (0.6) 1.9 (0.8) 1.1** (0.4) 2¥ (0.5) < 0.01
Control – Epidermis/GHBO* < GS
Medial – Epidermis/GHBO** = GNH€ < GS = GNAC 
Proximal – Epidermis/GHBO§ = GHN¥ < GNAC
Control – Dermis/without statistically significant difference
Medial – Dermis/GHBO* < GS = GNAC
Proximal – Dermis/GHBO§ <GS = GNAC
Control – Submuscular/without statistically significant difference
Medial – Submuscular/GHBO* < GS = GNAC
Proximal – Submuscular/GHBO** = GHN¥ < GS
Control – Vessels/without statistically significant difference
Medial – Vessels/GHBO* < GS 
Proximal – Vessels/GHBO** = GHN¥ < GS
***Analysis of variance, complemented by a post hoc Bonferroni test.
 GHN = GNAC + GHBO group; GNAC = N­acetylcysteine group; GHBO = hyperbaric oxygenation group; GS = sham group.
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or HBO. Because there was no difference between these 
groups and the control group, we suggest that the stimulus 
for angiogenesis was dependent on the bed on which the 
flap was placed after its confection. The growth of new 
vessels might have been delayed because there was no 
con tact with the bed.
Data regarding the mean number of apoptotic cells in 
the biopsied strata showed that, in the external part of the 
random flap, that is, where there was no ischemia, HBO (0.4 
± 0.5) promoted a greater decrease in caspase 3 expression 
compared with the GS (0.8 ± 0.9), GNAC (1.3 ± 0.5), and 
GHN (0.8 ± 0.7) groups. These findings allowed us to infer 
that HBO had a protective effect in the normal tissues by 
decreasing caspase 3 expression and that hyperoxidation 
tended to have a protective effect even in the tissues that 
were not exposed to ischemia; surgical trauma functions as 
a form of preconditioning.
The overall assessment of apoptosis in the various strata 
suggests that HBO has a protective effect on the medial and 
proximal portions of the flaps. HBO group presented redu ced 
caspase 3 expression in the external skin of the flap, indi­
cating that the effect of hyperoxygenation on healthy tissues 
was similar to that in tissues that only received the surgical 
stimulus or were treated with NAC. The effect of the use of 
NAC was not different from that in the control group, and 
the use of HBO did not produce a synergistic effect, which 
implies that the use of NAC as an antioxidant did not have 
a protective effect.
The combination of NAC with HBO yielded worse results 
than the isolated use of HBO. NAC concentrations greater 
than 20 mmol/L may reverse the antioxidant effect through 
pH inversion, cytochrome C activation, and mitochondrial 
pore opening, and thus lead to cell death11.
The results of this study suggest a clear reduction in 
apoptosis in the group treated with HBO. The most plausible 
hypothesis for the protective effect of HBO on cellular apop­
tosis is the abundant supply of oxygen to the tissues during the 
initial stage of ischemia, which attenuates the inflammatory 
response and reduces lipid peroxidation4­6.
CONCLUSIONS
Considering the positive effect of HBO on the reduction 
of cellular apoptosis, we suggest that this is dependent on the 
time of exposure or the number of exposures to hyperbaric 
oxygen. The rationale for using HBO, previously publi­
shed results, and the results of this study suggest that more 
prolonged or frequent daily sessions may result in decreased 
apoptosis. These conclusions still need to be confirmed in 
further studies in this area.
HBO, NAC, or the combination of both did not affect 
VEGF levels. This implied that the flap was exclusively de ­
pendent on the vascular pedicle when a polyethylene film 
was applied. HBO and NAC were not effective in increasing 
VEGF expression, demonstrating the absence of a stimulus 
for vascular neogenesis during the period under study.
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